Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2014

Open Access 01-12-2014 | Research article

Increased respiratory drive relates to severity of dyspnea in systemic sclerosis

Authors: Maarten K Ninaber, Willem BGJ Hamersma, Annemie JM Schuerwegh, Jan Stolk

Published in: BMC Pulmonary Medicine | Issue 1/2014

Login to get access

Abstract

Background

Dyspnea may be a presenting symptom in progressive systemic sclerosis (SSc). Respiratory drive (mouth occlusion pressure, MOP, at rest and during CO2 rebreathing, 7% CO2, 93% O2) is a major determinant of dyspnea and may relate to the magnitude of dyspnea.

Methods

In a prospective design, MOP at 0.1 sec (P0.1) was measured in 73 SSc patients while breathing room air and during CO2 rebreathing. An abnormal V’E/P0.1 is defined as < 8 L/min/cm H2O. Dyspnea scores were assessed by a shortness of breath questionnaire (UCSD dyspnea scale).

Results

Mean P0.1 in patients with normal V’E/P0.1 (n = 45) was 1.1 ± 0.04 and 1.6 ± 0.08 cm H2O in patients with abnormal V’E/P0.1 (n = 28), p <0.001. ∆P0.1/∆PetCO2 differed significantly between these groups (0.45 versus 0.75 cm H2O/mmHg, P < 0.001), but no significant difference was present in ∆V’E/∆PetCO2. V’E/P0.1 showed the highest significant correlation with the UCSD dyspnea score (r = -0.76, p <0.001). UCSD cut-off value for abnormal V’E/P0.1 was 8.5 (sensitivity 93%, specificity 96%, area under the curve 0.98).

Conclusions

In SSc patients an abnormal V’E/P0.1 better relates to the severity of dyspnea than traditional lung function parameters and can easily be assessed at first outpatient consultation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Black CM, Stephen C: Systemic Sclerosis (Scleroderma) And Related Disorders. Oxford Textbook of Rheumatology. Edited by: MadisonPJ IDA, WooP GDN. 1993, Oxford: Oxford University Press, 771- Black CM, Stephen C: Systemic Sclerosis (Scleroderma) And Related Disorders. Oxford Textbook of Rheumatology. Edited by: MadisonPJ IDA, WooP GDN. 1993, Oxford: Oxford University Press, 771-
2.
go back to reference LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, Rowell N, Wollheim F: Scleroderma (systemic sclerosis): classification, subsets and pathogenenis. J Rheumatol. 1988, 15: 202-205.PubMed LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, Rowell N, Wollheim F: Scleroderma (systemic sclerosis): classification, subsets and pathogenenis. J Rheumatol. 1988, 15: 202-205.PubMed
3.
go back to reference Whitelaw WA, Derenne JP, Milic-Emili J: Occlusion pressure as a measure of respiratory center output in conscious man. Resp Physiol. 1975, 23: 181-199. 10.1016/0034-5687(75)90059-6.CrossRef Whitelaw WA, Derenne JP, Milic-Emili J: Occlusion pressure as a measure of respiratory center output in conscious man. Resp Physiol. 1975, 23: 181-199. 10.1016/0034-5687(75)90059-6.CrossRef
4.
go back to reference Nageh TT, Du Bois RM: Non-invasive ventilation in hypercapnic respiratory failure secondary to sclerodermic chest wall restriction. Respir Med. 1998, 92: 1170-1172. 10.1016/S0954-6111(98)90414-0.CrossRefPubMed Nageh TT, Du Bois RM: Non-invasive ventilation in hypercapnic respiratory failure secondary to sclerodermic chest wall restriction. Respir Med. 1998, 92: 1170-1172. 10.1016/S0954-6111(98)90414-0.CrossRefPubMed
5.
go back to reference Pugazhenthi M, Cooper D, Ratnakant BS, Postlethwaite A, Carbone L: Hypercapnic respiratory failure in systemic sclerosis. J Clin Rheumatol. 2003, 9: 43-46. 10.1097/01.RHU.0000049714.86978.77.CrossRefPubMed Pugazhenthi M, Cooper D, Ratnakant BS, Postlethwaite A, Carbone L: Hypercapnic respiratory failure in systemic sclerosis. J Clin Rheumatol. 2003, 9: 43-46. 10.1097/01.RHU.0000049714.86978.77.CrossRefPubMed
6.
go back to reference Cherniack RM, Snidal DP: The effect of obstruction to breathing on the ventilatory response to CO2. J Clin Invest. 1956, 35: 1286-1290. 10.1172/JCI103383.CrossRefPubMedPubMedCentral Cherniack RM, Snidal DP: The effect of obstruction to breathing on the ventilatory response to CO2. J Clin Invest. 1956, 35: 1286-1290. 10.1172/JCI103383.CrossRefPubMedPubMedCentral
7.
go back to reference Gorini M, Spinelli A, Ginanni R, Duranti R, Gigliotti F, Arcangeli P, Scano G: Neural respiratory drive and neuromuscular coupling with CO2 rebreathing in patients with chronic interstitial lung disease. Chest. 1989, 96: 824-830. 10.1378/chest.96.4.824.CrossRefPubMed Gorini M, Spinelli A, Ginanni R, Duranti R, Gigliotti F, Arcangeli P, Scano G: Neural respiratory drive and neuromuscular coupling with CO2 rebreathing in patients with chronic interstitial lung disease. Chest. 1989, 96: 824-830. 10.1378/chest.96.4.824.CrossRefPubMed
8.
go back to reference Patrick J: The influence of age, sex, body size and lung size on the control and pattern of breathing during CO2 inhalation in Caucasians. Respir Physiol. 1972, 16: 337-350. 10.1016/0034-5687(72)90063-1.CrossRefPubMed Patrick J: The influence of age, sex, body size and lung size on the control and pattern of breathing during CO2 inhalation in Caucasians. Respir Physiol. 1972, 16: 337-350. 10.1016/0034-5687(72)90063-1.CrossRefPubMed
9.
go back to reference Milic-Emili J, Whitelaw WA, Derenne JP: Occlusion pressure, a simple measure of the respiratory center output. N Engl J Med. 1975, 293: 1029-1031. 10.1056/NEJM197511132932006.CrossRefPubMed Milic-Emili J, Whitelaw WA, Derenne JP: Occlusion pressure, a simple measure of the respiratory center output. N Engl J Med. 1975, 293: 1029-1031. 10.1056/NEJM197511132932006.CrossRefPubMed
10.
go back to reference Scott GC, Burki NK: The relationship between resting ventilation to mouth occlusion pressure. An index of resting respiratory function. Chest. 1990, 98: 900-906. 10.1378/chest.98.4.900.CrossRefPubMed Scott GC, Burki NK: The relationship between resting ventilation to mouth occlusion pressure. An index of resting respiratory function. Chest. 1990, 98: 900-906. 10.1378/chest.98.4.900.CrossRefPubMed
11.
go back to reference Calverley PMA: Ventilatory Control And Dyspnea. Chronic Obstructive Pulmonary Disease. Edited by: Calverley PMA, Pride NB. 1995, London: Chapman and Hall, 205-242.CrossRef Calverley PMA: Ventilatory Control And Dyspnea. Chronic Obstructive Pulmonary Disease. Edited by: Calverley PMA, Pride NB. 1995, London: Chapman and Hall, 205-242.CrossRef
12.
go back to reference ATS Board of Directors: ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002, 166: 518-624.CrossRef ATS Board of Directors: ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002, 166: 518-624.CrossRef
13.
go back to reference Jordan C: Automatic method for measuring mouth occlusion pressure response to carbon dioxide inhalation. Med Biol Eng Comput. 1981, 19: 279-286. 10.1007/BF02442545.CrossRefPubMed Jordan C: Automatic method for measuring mouth occlusion pressure response to carbon dioxide inhalation. Med Biol Eng Comput. 1981, 19: 279-286. 10.1007/BF02442545.CrossRefPubMed
14.
go back to reference MacIntyre N: Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005, 26: 720-735. 10.1183/09031936.05.00034905.CrossRefPubMed MacIntyre N: Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005, 26: 720-735. 10.1183/09031936.05.00034905.CrossRefPubMed
15.
go back to reference Miller MR: Standardisation of spirometry. Eur Respir J. 2005, 26: 319-338. 10.1183/09031936.05.00034805.CrossRefPubMed Miller MR: Standardisation of spirometry. Eur Respir J. 2005, 26: 319-338. 10.1183/09031936.05.00034805.CrossRefPubMed
16.
go back to reference Montes de Oca M, Celli BR: Mouth occlusion pressure, CO2 response and hypercapnia in severe obstructive pulmonary disease. Eur Respir J. 1998, 12: 666-671. 10.1183/09031936.98.12030666.CrossRefPubMed Montes de Oca M, Celli BR: Mouth occlusion pressure, CO2 response and hypercapnia in severe obstructive pulmonary disease. Eur Respir J. 1998, 12: 666-671. 10.1183/09031936.98.12030666.CrossRefPubMed
17.
go back to reference Read DJC: A clinical method for assessing ventilatory response to carbon dioxide. Aust Ann Med. 1967, 16: 20-32.PubMed Read DJC: A clinical method for assessing ventilatory response to carbon dioxide. Aust Ann Med. 1967, 16: 20-32.PubMed
18.
go back to reference Rietjens GJWM, Kuipers H, Kester ADM, Keizer HA: Validation of a computerized metabolic measurement system (Oxycon-Pro) during low and high intensity exercise. Int J Sports Med. 2001, 22: 291-294. 10.1055/s-2001-14342.CrossRefPubMed Rietjens GJWM, Kuipers H, Kester ADM, Keizer HA: Validation of a computerized metabolic measurement system (Oxycon-Pro) during low and high intensity exercise. Int J Sports Med. 2001, 22: 291-294. 10.1055/s-2001-14342.CrossRefPubMed
19.
go back to reference Eakin EG, Resnikoff PM, Prewitt LM, Ries AL, Kaplan RM: Validation of a new dyspnea measure. The UCSD shortness of breath questionnaire. Chest. 1998, 113: 619-624. 10.1378/chest.113.3.619.CrossRefPubMed Eakin EG, Resnikoff PM, Prewitt LM, Ries AL, Kaplan RM: Validation of a new dyspnea measure. The UCSD shortness of breath questionnaire. Chest. 1998, 113: 619-624. 10.1378/chest.113.3.619.CrossRefPubMed
20.
go back to reference Nishino T: Dyspnoea: underlying mechanisms and treatment. Br J Anaesth. 2011, 106: 463-474. 10.1093/bja/aer040.CrossRefPubMed Nishino T: Dyspnoea: underlying mechanisms and treatment. Br J Anaesth. 2011, 106: 463-474. 10.1093/bja/aer040.CrossRefPubMed
21.
go back to reference Walterspacher S, Schlager D, Walker DJ, Muller-Quernheim J, Windisch W, Kabitz HJ: Respiratory muscle function in interstitial lung disease. Eur Respir J. 2013, 42: 211-219. 10.1183/09031936.00109512.CrossRefPubMed Walterspacher S, Schlager D, Walker DJ, Muller-Quernheim J, Windisch W, Kabitz HJ: Respiratory muscle function in interstitial lung disease. Eur Respir J. 2013, 42: 211-219. 10.1183/09031936.00109512.CrossRefPubMed
22.
go back to reference DiMarco AF, Kelsen SG, Cherniack NS, Gothe B: Occlusion pressure and breathing pattern in patients with interstitial lung disease. Am Rev Respir Dis. 1983, 127: 425-430.CrossRefPubMed DiMarco AF, Kelsen SG, Cherniack NS, Gothe B: Occlusion pressure and breathing pattern in patients with interstitial lung disease. Am Rev Respir Dis. 1983, 127: 425-430.CrossRefPubMed
Metadata
Title
Increased respiratory drive relates to severity of dyspnea in systemic sclerosis
Authors
Maarten K Ninaber
Willem BGJ Hamersma
Annemie JM Schuerwegh
Jan Stolk
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2014
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/1471-2466-14-57

Other articles of this Issue 1/2014

BMC Pulmonary Medicine 1/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.